Breakthrough in remote medical assistance

NewsGuard 100/100 Score

By the year 2026, 21.6 per cent of the world's population will be older than 65, 32 per cent of which will have some kind of disability.

Official data confirm that the percentage of elderly people will increase dramatically within the next years: by 2050 there will be 180 per cent more people older than 80 than today.

Guided by these figures, the Spanish Ministry of Industry, Tourism and Trade , through its CENIT programme, targeted at fostering cooperation between the private and the public sectors for the development of technological innovations, has granted a 20 million euro subsidy to the research and development project "AmIVital: digital personal environment for health and wellbeing".

Seventeen Spanish top Information and Communication Technology companies and research groups participate in AmIVital. From the private side, SIEMENS will be the leader of this project in which other companies take part, such as Telef'nica R&D, Telvent Interactiva, Ericsson Spain, Eptron, CPI , Central de Procesos Inform'ticos, Acerca Comunicaciones y Sistemas and Arizone. Public stakeholders will include the association ITACA , Instituto de Aplicaciones de las TIC Avanzadas (TSB Group), CARTIF Foundation, Hospital Universitario Puerta de Hierro Biomedical Research Foundation, Rioja Salud Foundation, Carlos III Health Institute and the universities of Malaga, Polytechnic of Madrid, Saragossa and Granada, through its department of Computer Architecture headed by professor Alberto Prieto Espinosa.

The official presentation of the project took place on May 8th, at the University of Granada where the head of the University Department of Research, professor Rafael Pay, Albert, highlighted that AmIVital is the second economic project in the history of this institution, with an investment of more than 850,000 euros.

A breakthrough in remote assistance

According to the heads of this ambitious project, unprecedented in Spain, AmIVital will not only allow for the development of specific ready-to-use products, but it will also set up a technological platform comprising device, network and computer programme standardized components allowing for a simple creation of services adapted to different needs and environments. In simpler words, this cooperation between companies and research centres will represent "a breakthrough in the field of remote assistance", thanks to the creation of intelligent devices, biosensors, portable systems (integrated into the human body or into clothes), ubiquitous wireless networks, multimodal interfaces (PCs, PDAs, telephones, etc.). A wide range of devices especially designed and adapted to the elderly and to people with disabilities or reduced mobility that will be marketed in the foreseeable future by the companies taking part in the project.

Granada was chosen as the city to launch AmIVital because of its high concentration of companies and regional public research bodies, as well as due to the support provided to the project by the Andalusian Regional Government through its department of Innovation, Science and Business. Not surprisingly, at the presentation of the project, the delegate advisor of the public telecommunications company SADETEL announced that AmIVital technological results will be piloted with Andalusian real patients, already users of remote assistance services provided by the Regional Government.

The head of the AmIVital project, also head of the SIEMENS Organization and Research department, Luis F. Reigosa Gago, and the head of the Telef'nica R&D Centre in Granada, Luis Carlos Fernandez Gonzalez, stated that even though the project will be developed throughout the next four years, "the first results and their direct application to patients will take place in the short run".

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Rising antibiotic resistance prompts shift to ecological research strategies in infection control